Concepedia

Publication | Open Access

Phase II Study of Combination Chemotherapy with Gemcitabine and Cisplatin for Patients with Metastatic Pancreatic Cancer

12

Citations

21

References

2007

Year

Abstract

The combination of gemcitabine and cisplatin administered by this schedule produced a good response rate associated with moderate but manageable toxicities in patients with metastatic pancreatic cancer.

References

YearCitations

Page 1